Still lack of knowledge regarding Medicare’s Part D prescription drug program
There still appears to be some lack of knowledge regarding Medicare‘s Part D prescription drug program, although there is evidence that cost-related medication nonadherence may have improved overall, according to two studies in the April 23/30 issue of JAMA, the Journal of the American Medical Association.